AI Article Synopsis
Article Abstract
Chronic acquired neuropathies of unknown origin are classified as chronic inflammatory demyelinating polyneuropathies (CIDP) and chronic idiopathic axonal polyneuropathies (CIAP). The diagnosis can be very difficult, although it has important therapeutic implications since CIDP can be improved by immunomodulating treatment. The aim of this study was to examine the possible abnormalities of nodal and paranodal regions in these two types of neuropathies. Longitudinal sections of superficial peroneal nerves were obtained from biopsy material from 12 patients with CIDP and 10 patients with CIAP and studied by immunofluorescence and in some cases electron microscopy. Electron microscopy revealed multiple alterations in the nodal and paranodal regions which predominated in Schwann cells in CIDP and in axons in CIAP. In CIDP paranodin/Caspr immunofluorescence was more widespread than in control nerves, extending along the axon in internodes where it appeared intense. Nodal channels Nav and KCNQ2 were less altered but were also detected in the internodes. In CIAP paranodes, paranodin labeling was irregular and/or decreased. To test the consequences of acquired primary Schwann cells alteration on axonal proteins, we used a mouse model based on induced deletion of the transcription factor Krox-20 gene. In the demyelinated sciatic nerves of these mice we observed alterations similar to those found in CIDP by immunofluorescence, and immunoblotting demonstrated increased levels of paranodin. Finally we examined whether the alterations in paranodin immunoreactivity could have a diagnosis value. In a sample of 16 biopsies, the study of paranodin immunofluorescence by blind evaluators led to correct diagnosis in 70 ± 4% of the cases. This study characterizes for the first time the abnormalities of nodes of Ranvier in CIAP and CIDP, and the altered expression and distribution of nodal and paranodal proteins. Marked differences were observed between CIDP and CIAP and the alterations in paranodin immunofluorescence may be an interesting tool for their differential diagnosis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022580 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0014533 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond.
Int J Mol Sci
November 2024
Neurochemistry Group, Institute of NeuroScience, Université Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.
Neurodegeneration is preeminent in many neurological diseases, and still a major burden we fail to manage in patient's care. Its pathogenesis is complicated, intricate, and far from being completely understood. Taking multiple sclerosis as an example, we propose that neurodegeneration is neither a cause nor a consequence by itself.
View Article and Find Full Text PDFPrevalence and clinical implications of diabetes mellitus in autoimmune nodopathies: A systematic review.
J Diabetes Complications
December 2024
Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Article Synopsis
- Autoimmune nodopathies are a new type of immune-mediated peripheral neuropathies linked to autoantibodies targeting specific proteins, with evidence showing an increased risk for these conditions in diabetes mellitus (DM) patients.* -
- A systematic review identified 114 patients with autoimmune nodopathies, revealing that the prevalence of DM among them varied from 10.5% to 60%, predominantly with paranodal antibodies like CNTN1.* -
- Key distinctive clinical features of autoimmune nodopathies compared to diabetic peripheral neuropathy included severe ataxia, specific neurophysiological patterns, and abnormal findings in cerebrospinal fluid analysis, while DM patients showed limited response to standard treatments.*
Case report: target antigen and subclass switch in a patient with autoimmune nodopathy.
Front Immunol
October 2024
Department of Neurology, University Hospital Würzburg, Würzburg, Germany.
Introduction: Autoimmune nodopathy (AN) is a new entity in the field of peripheral neuropathies and is defined by the presence of auto-antibodies against structures of the node of Ranvier combined with specific clinico-pathophysiological features and therapy response in affected patients. The target-specific antibodies do not only serve as diagnostic biomarkers but also for treatment evaluation during follow-up.
Case Report: We report a 66-year-old female patient with various autoimmune diseases, including a history of membranous glomerulonephritis which presented with acute-onset, sensorimotor tetraparesis, cranial nerve involvement, and mild respiratory insufficiency.
Immune-Mediated Neuropathies: Top 10 Clinical Pearls.
Semin Neurol
October 2024
Vagelos College of Physicians and Surgeons, Columbia University, New York, New York.
Immune-mediated neuropathies encompass a range of neurological disorders, including chronic inflammatory demyelinating polyradiculoneuropathy, Guillain-Barré syndrome, multifocal motor neuropathy, autoimmune autonomic neuropathies, and paranodal nodopathies. Recognizing clinical patterns is key to narrowing the broad range of differential diagnoses in immune-mediated neuropathies. Electrodiagnostic testing is a useful tool to support the diagnosis of immune-mediated neuropathies.
View Article and Find Full Text PDFCharacteristics of anti-contactin1 antibody positive autoimmune nodopathies combined with membranous nephropathy.
J Neuroimmunol
November 2024
Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China; Shandong Institute of Neuroimmunology, Jinan, China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, China; Department of Neurology, Shandong Provincial Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. Electronic address:
Article Synopsis
- Autoimmune nodopathy (AN) is a rare disease that can occur alongside membranous nephropathy (MN), and it involves the presence of specific antibodies in the serum.
- A study was done on a 65-year-old male with MN who exhibited symptoms like limb numbness and walking instability, revealing positive anti-CNTN1 antibodies, primarily of the IgG4 subtype, and significant nerve damage.
- The comparison of 35 cases of AN with MN to 51 cases of AN without MN found similar clinical characteristics, suggesting that while AN's symptoms may appear with MN, they do not worsen or improve with the presence of MN.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!